Abstract
Hepatitis C virus infection is a global public health issue， and the emergence of direct-acting antiviral agents has brought revolutionary breakthroughs in the treatment of hepatitis C patients. Although direct-acting antiviral agents have a marked therapeutic effect in adult patients， there are still many challenges in the treatment of special populations such as pregnant women， infants， young children， and adolescents. This article reviews the current status of antiviral therapy for these special populations with hepatitis C and the problems that need to be solved， in order to provide reference and guidance for clinical workers.
| Translated title of the contribution | Management of hepatitis C in children and pregnant women |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 654-658 |
| Number of pages | 5 |
| Journal | Journal of Clinical Hepatology |
| Volume | 40 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2024 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Management of hepatitis C in children and pregnant women'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver